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EssayHistorically, the word “epigenetics” 
was used to describe events that could 
not be explained by genetic principles. 
Conrad Waddington (1905–1975), who 
is given credit for coining the term, 
defined epigenetics as “the branch 
of biology which studies the causal 
interactions between genes and their 
products, which bring the phenotype 
into being” (Waddington, 1942). Over 
the years, numerous biological phe-
nomena, some considered bizarre and 
inexplicable, have been lumped into the 
category of epigenetics. These include 
seemingly unrelated processes, such 
as paramutation in maize (an interac-
tion between two alleles in which one 
allele causes heritable changes in the 
other allele); position effect variega-
tion in the fruit fly Drosophila (in which 
the local chromatin environment of 
a gene determines its expression); 
and imprinting of specific 
paternal or maternal loci in 
mammals. Although myster-
ies abound, the field is now 
beginning to uncover com-
mon molecular mechanisms 
underlying epigenetic phe-
nomena. We have recently 
witnessed an explosion of 
research efforts, meetings 
and symposia, international 
initiatives, internet resources, 
commercial enterprises, and 
even a recent textbook dedi-
cated to epigenetics, all of 
which lead us to this year’s 
special review issue in Cell. 
What underlies this swell 
of interest in epigenetics? 
Whether it is the enigma of 
epigenetic processes or their 
fundamental importance in 
myriad biological contexts, one thing is 
clear—the field of epigenetics is gain-
ing respect.
Epigenetics, in a broad sense, is a 
bridge between genotype and pheno-
type—a phenomenon that changes the 
final outcome of a locus or chromo-
some without changing the underly-
ing DNA sequence. For example, even 
though the vast majority of cells in a 
multicellular organism share an identi-
cal genotype, organismal development 
generates a diversity of cell types with 
disparate, yet stable, profiles of gene 
expression and distinct cellular func-
tions. Thus, cellular differentiation may 
be considered an epigenetic phenom-
enon, largely governed by changes in 
what Waddington described as the 
“epigenetic landscape” rather than 
alterations in genetic inheritance (Wad-
dington, 1957; Figure 1). More spe-
cifically, epigenetics may be defined 
as the study of any potentially stable 
and, ideally, heritable change in gene 
expression or cellular phenotype that 
occurs without changes in Watson-
Crick base-pairing of DNA.
Here, we aim to briefly introduce 
some of the core molecular actors 
that play upon the epigenetic stage 
and touch upon concepts of epige-
netic heritability and stability. Despite 
the field’s recent progress, significant 
and fundamental questions remain to 
be answered, many of which center on 
the propagation of epigenetic informa-
tion through cellular division and differ-
entiation. We highlight some of these 
questions as challenges to the emerg-
ing field. We also refer readers to the 
review articles appearing in this special 
issue, as well as a new textbook enti-
tled Epigenetics (Allis et al., 2007; see 
Book Review by Y. Shi, page 
639 of this issue).
Epigenetic Mechanisms  
at Work
Much of today’s epigenetic 
research is converging on 
the study of covalent and 
noncovalent modifications 
of DNA and histone proteins 
and the mechanisms by 
which such modifications 
influence overall chromatin 
structure. Chromatin, the 
complex of DNA and its inti-
mately associated proteins, 
provides an attractive can-
didate for shaping the fea-
tures of a cell’s epigenetic 
landscape (see Review by 
B.E. Bernstein et al., page 
669 of this issue). Diverse 
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provide a brief overview of underlying molecular mechanisms, and suggest future 
 challenges for the field.
Figure 1. Waddington’s Classical Epigenetic Landscape
In 1957, Conrad Waddington proposed the concept of an epigenetic 
landscape to represent the process of cellular decision-making dur-
ing development. At various points in this dynamic visual metaphor, 
the cell (represented by a ball) can take specific permitted trajecto-
ries, leading to different outcomes or cell fates. Figure reprinted from 
Waddington, 1957.Cell 128, February 23, 2007 ©2007 Elsevier Inc. 635
epigenetic phenomena have recently 
led researchers to conserved molec-
ular mechanisms involving chroma-
tin modification, a theme reinforced 
throughout this special issue. We favor 
the view that the macromolecular enti-
ties described below all significantly 
contribute to the physiologically rel-
evant organization of most eukaryotic 
genomes. These entities, and possibly 
others yet unknown, should be con-
sidered collectively when exploring 
epigenetic mechanisms.
DNA Methylation
DNA methylation is perhaps the best 
characterized chemical modification 
of chromatin. In mammals, nearly all 
DNA methylation occurs on cyto-
sine residues of CpG dinucleotides. 
Regions of the genome that have a 
high density of CpGs are referred to 
as CpG islands, and DNA methyla-
tion of these islands correlates with 
transcriptional repression (Goll and 
Bestor, 2005). Genomic patterns 
of cytosine methylation in mam-
mals, whether donated by de novo 
or maintenance DNA methyltrans-
ferases (DNMTs), play a critical role 
in gene regulation and chromatin 
organization during embryogenesis 
and gametogenesis (Goll and Bestor, 
2005; see Review by M.A. Surani et 
al., page 747 of this issue). Mainte-
nance methyltransferases add methyl 
groups to hemi-methylated DNA 
during DNA replication, whereas de 
novo DNMTs act after DNA replica-
tion (see Review by A. Groth et al., 
page 721 of this issue). Moreover, 
the formation of heterochromatin in 
many organisms is mediated in part 
by DNA methylation and its binding 
proteins in combination with RNA 
and histone modifications character-
istic of silent chromatin (see Review 
by M. Zaratiegui et al., page 763 of 
this issue). DNA methylation plays 
a role in many cellular processes 
including silencing of repetitive and 
centromeric sequences from fungi to 
mammals; X chromosome inactiva-
tion in female mammals; and mam-
malian imprinting, all of which can 
be stably maintained (see Review 
by P.K. Yang and  K.I. Kuroda, page 
777 of this issue). Taken together, 636 Cell 128, February 23, 2007 ©2007 EDNA methylation provides a stable, 
heritable, and critical component of 
epigenetic regulation.
Chromatin Variation: Covalent 
and Noncovalent Mechanisms
The list of covalent modifications to 
histone proteins continues to grow 
(see Review by T. Kouzarides, page 
693 of this issue). However, only 
recently has genetic and biochemical 
evidence converged to clearly con-
nect covalent histone modifications 
with longstanding epigenetic phenom-
ena. Genetic screens for suppressors 
of position effect variegation [Su(var)] 
in Drosophila, for example, revealed 
over 100 genes that encode vital con-
stituents of heterochromatin. Many of 
these genes are conserved from flies 
to humans, including heterochromatin 
protein 1 (HP1) and the histone H3K9 
methyltransferase Su(var)3-9 (Schotta 
et al., 2003). Drosophila genetics also 
provides another link between epi-
genetics and histone modifications, 
in the form of two evolutionarily con-
served families of proteins that regu-
late homeotic genes antagonistically 
during development: the Polycomb 
Group (PcG) and the Trithorax Group 
(TrxG). Further molecular characteriza-
tion of PcG proteins reveals that they 
contribute to two distinct protein com-
plexes that are responsible for “writing” 
(PRC2, Polycomb Repressive Complex 
2) and “reading” (PRC1) methylation of 
H3K27 and facilitating chromatin con-
densation. Meanwhile, TrxG proteins 
mediate methylation of H3K4 and pro-
mote transcriptionally active chromatin 
(Ringrose and Paro, 2004; Ruthenburg 
et al., 2007; Review by B. Schuetten-
gruber et al., page 735 of this issue)
How might covalent histone modi-
fications modify chromatin structure 
to influence patterns of gene expres-
sion (Jenuwein and Allis, 2001)? A 
longstanding literature suggests that 
charge-altering modifications such 
as acetylation and phosphorylation 
can directly alter the physical proper-
ties of the chromatin fiber, leading to 
changes in higher-order structures. 
More recently, effector-mediated func-
tions have been well documented, 
whereby histone modifications recruit 
or stabilize the localization of specific lsevier Inc.binding partners to chromatin. In the 
first example of an emerging epige-
netic paradigm, the catalytic enzyme 
Su(var)3-9 serves as a “writer” of his-
tone H3K9 methylation, whereas HP1 
serves as a “reader” or “effector” rec-
ognizing H3K9 methylation and direct-
ing biological processes (such as het-
erochromatin stabilization) to particular 
areas of the chromatin fiber (Lachner et 
al., 2001). In addition, effector-repulsive 
functions have been demonstrated in 
which histone modifications abrogate 
the binding of particular effectors (Fis-
chle et al., 2005; T.H. Bestor, personal 
communication).
Noncovalent mechanisms such as 
chromatin remodeling and the incor-
poration of specialized histone vari-
ants provide the cell with additional 
tools for introducing variation into the 
chromatin template. ATP-depend-
ent chromatin remodeling complexes 
are thought to modify chromatin 
accessibility by altering histone-
DNA interactions, perhaps by slid-
ing or ejecting nucleosomes (Smith 
and Peterson, 2005). In addition, 
histone variants such as H3.3 and 
H2A.Z, often carrying their own modi-
fication patterns, are exchanged within 
chromosomal domains by dedicated 
chaperone and exchange machinery 
(Polo and Almouzni, 2006). Mecha-
nistic links between covalent and non-
covalent mechanisms have also been 
uncovered, as effectors can include 
subunits of nucleosome remodeling 
complexes (Wysocka et al., 2006). 
Covalent modification, nucleosome 
remodeling, and histone variants work 
together to introduce meaningful vari-
ation into the chromatin fiber, and their 
collective contribution to epigenetics 
is only now being rigorously explored.
Noncoding RNA
Recently, it has become evident that 
RNA, particularly noncoding RNAs, 
have a hand in controlling multiple epi-
genetic phenomena (Bernstein and 
Allis, 2005). Clear examples of RNA 
involvement range from dosage com-
pensation mechanisms in Drosophila 
and mammals mediated by the rox 
and XIST RNAs, respectively, to the 
silencing of both genes and repetitive 
DNA sequences by posttranscriptional 
(PTGS) and transcriptional 
(TGS) RNA interference 
(RNAi)-related pathways, 
respectively, in almost all 
eukaryotes. These RNAs 
often act in concert with 
various components of the 
cell’s chromatin and DNA 
methylation machinery to 
achieve stable silencing. 
Although we might not con-
sider PTGS-inducing RNAs 
(e.g., microRNAs, siRNAs, 
etc.) to be epigenetic in 
nature, TGS-evoking RNAs 
(e.g., repeat-associated siR-
NAs, Xist RNA, and small 
RNAs in S. pombe) are more 
clearly epigenetic, as they 
can induce long-term silenc-
ing effects that can be inher-
ited through cell division 
(Bernstein and Allis, 2005).
Epigenetic Pathways 
Intersect
It is becoming clear that 
significant crosstalk exists 
between different epigenetic 
pathways. In S. pombe, for 
example, biochemical puri-
fication of the RNAi machin-
ery revealed an interaction 
between small RNAs and 
chromatin regulators such 
as the H3K9me-reading 
chromodomain-contain-
ing protein Chp1 (Grewal 
and Jia, 2007). Silencing of 
the inactive X chromosome 
is another prime exam-
ple, where Xist RNA, DNA 
methylation, histone modi-
fications, and their writers 
and readers all play a role 
(Heard, 2005). Moreover, DNMTs act in 
part by interacting directly or indirectly 
with chromatin-modifying enzymes 
such as histone deacetylases (Dobosy 
and Selker, 2001). New studies reveal 
that DNMT3L, an essential accessory 
protein to the de novo DNMTs in the 
germline, interprets patterns of histone 
modifications, adding weight to an 
emerging theme that DNA methylation 
and histone modifications functionally 
interact (Freitag and Selker, 2005; T.H. 
Bestor, personal communication).
Questions and Challenges
If modifications to DNA and chromatin 
along with the expression of specific 
noncoding RNAs help to define epi-
genetic identity, how are these factors 
inherited through cell division? What 
mechanisms enable epigenetic stabil-
ity in a defined cellular lineage while 
allowing epigenetic flexibility during 
cellular differentiation and develop-
ment? Mechanisms exist for the faith-
ful propagation of DNA sequences 
and even DNA methylation patterns 
during replication, yet we 
understand comparatively 
little about non-DNA-based 
epigenetic inheritance.
Key questions regarding 
chromatin-based inherit-
ance surprisingly remain 
unanswered. For example, 
are histone modifications 
inherited through replica-
tion, and if so, how does 
this occur (see Review by A. 
Groth et al., page 721 of this 
issue)? How do newly incor-
porated histones “learn” 
from parental chromatin? Is 
there an active mechanism 
for templating histone modi-
fications during DNA repli-
cation? Is templating of new 
histone modifications simply 
a consequence of spreading 
to adjacent nucleosomes, 
as in position effect vari-
egation? Or is templating of 
parental modifications onto 
new histones even neces-
sary? Are half of the modi-
fications enough? If histone 
modifications help to define 
cellular identity, mecha-
nisms should exist for tem-
plating of new histone modi-
fications, or such marks 
would be quickly diluted out 
in rapidly dividing cells.
Numerous related ques-
tions remain. Throughout 
development, a multipo-
tent stem cell can become 
many different cell types, 
each genetically identi-
cal but unique in cellular 
phenotype (Figure 1). After 
a lineage transition, how 
is the epigenetic identity of spe-
cific differentiated cell types stably 
inherited? How does RNA fit into 
the issue of chromatin inheritance, 
if at all? With the recent discover-
ies of histone lysine demethylases, 
how do these “erasers” of covalent 
modifications function in epigenetic 
phenomena? Are all modifications 
actively erased? What factors are 
responsible for the reversal of DNA 
methylation patterns during game-
togenesis and early development? 
Figure 2. A Current View of the Epigenetic Molecular 
Machinery
Known factors that regulate epigenetic phenomena are shown directing 
the complex movement of pinballs (cells) across the elegant landscape 
proposed by Waddington (see Figure 1). No specific order of molecu-
lar events is implied; as such a sequence remains unknown. Effector 
proteins recognize specific histone modifications, while presenters are 
proposed to impart substrate specificity for histone-modifying enzymes 
(Ruthenburg et al., 2007). H3.3 and macroH2A are shown only as repre-
sentative histone variants involved in transcriptional activation or repres-
sion, respectively. For simplicity, other histone (and nonhistone) proteins 
are not shown. (ChR, chromatin remodelers; DNMTs, DNA methyltrans-
ferases; HATs, histone acetyltransferases; HDACs, histone deacetylases; 
HMTs, histone methyltransferases; HDMs, histone demethylases; DDMs, 
DNA demethylases [unidentified in mammals to date]; and TFs, transcrip-
tion factors [reflecting the genetic component of the epigenetic process].) 
Illustration by Sue Ann Fung-Ho.Cell 128, February 23, 2007 ©2007 Elsevier Inc. 637
How do we reconcile proposed DNA 
demethylases and known histone 
demethylases with the notion of 
methylation as a stable epigenetic 
indexing system? How are demethy-
lases regulated? The emerging dia-
lectic of epigenetics, including the 
marks, writers, presenters, readers, 
and erasers, promises to be a rich 
conversation (see Review by M.A. 
Surani et al., page 747 of this issue).
Finally, we need a better molecu-
lar understanding of epigenetic phe-
nomena in human development and 
disease. Genomic reprogramming 
during germ cell specification and 
early embryonic development, as 
well as during somatic cell nuclear 
transfer and therapeutic cloning, is by 
definition an epigenetic process. Yet, 
despite its importance and impact in 
basic biology and regenerative medi-
cine, the molecular mechanisms of 
reprogramming remain poorly under-
stood (see review by M.A. Surani et 
al., page 747 of this issue). Moreo-
ver, DNA methylation systems and 
the chromatin machinery that writes 
and interprets histone modifications 
are clearly involved in disease states, 
particularly cancer (Sparmann and 
van Lohuizen, 2006; Yoo and Jones, 
2006; see Review by P.A. Jones and 
S.B. Baylin, page 683 of this issue). 
Are alterations in epigenetic pathways 
the cause or effect of the diseases in 
question? Despite these uncertain-
ties, therapeutic inhibition of histone 
deacetylation and DNA methylation is 
already proving useful in clinical trials 
of cancer therapies (Yoo and Jones, 
2006). As we venture into human 
biology, how do we move the field of 
epigenetics out of the cell and into 
the organism? While the field of chro-
matin biology has been revolution-
ized by biochemical approaches, we 
should welcome studies that apply the 
powerful tools of genetics to validate 
newly discovered molecular pathways 
as genuine players in epigenetics and 
developmental biology.
Epigenetics Today and Tomorrow
We are excited by the emergence of 
epigenetics as an accepted field of 
inquiry, by the recent convergence 
of epigenetic molecular mecha-638 Cell 128, February 23, 2007 ©2007 nisms on chromatin modification, 
and by the promise of continued 
epigenetic research in human devel-
opment and disease. As with any 
emerging field, many challenges 
remain, particularly with regard to 
the propagation of epigenetic infor-
mation through cellular division and 
differentiation. Indeed, questions 
regarding the stability and inherit-
ance of chromatin modifications, 
during and outside of DNA replica-
tion, must be resolved before con-
sidering histones and associated 
nonhistone proteins as true carriers 
of epigenetic information.
Modifications to chromatin have 
clearly emerged as a core mecha-
nism for regulating the transcrip-
tional status of a genetic locus, 
whether a small element within an 
individual gene, a chromosomal 
domain, or even an entire chromo-
some. However, while transcrip-
tional control and chromatin-related 
mechanisms are intense areas of 
research (see review by B. Li et al., 
page 707 of this issue), we should 
keep an open mind about non-chro-
matin and even non-nuclear epi-
genetic mechanisms, as new phe-
nomena continue to be explored. A 
good example is the regulation of 
the HOTHEAD gene in Arabidopsis, 
where an inherited RNA cache has 
been proposed as a possible expla-
nation for non-Mendelian inherit-
ance (Lolle et al., 2005).
Epigenetics as a research area is 
steeped in a rich literature, but its 
acceptance as a field has been hin-
dered by the view that it is a mere 
collection of curious but scattered 
phenomena documented in a wide 
range of organisms (Allis et al., 2007). 
Now the molecular mechanisms 
underlying diverse epigenetic proc-
esses are being defined at a remark-
able pace; key players and pathways 
are being uncovered with new tools 
and approaches (Figure 2). Many 
challenges remain, but we agree 
with James Watson that “the major 
problem, I think, is chromatin… you 
can inherit something beyond the 
DNA sequence. That’s where the 
real excitement of genetics is now” 
(Watson, 2003).Elsevier Inc.ACknoWLEdgMEnTS
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